Itron (NASDAQ:ITRI) Rating Lowered to “Hold” at Wall Street Zen

Itron (NASDAQ:ITRI) was downgraded by analysts at Wall Street Zen from a “buy” rating to a “hold” rating in a research report issued on Monday.

Other equities research analysts have also issued research reports about the company. Weiss Ratings reaffirmed a “buy (b-)” rating on shares of Itron in a research note on Monday, December 22nd. Robert W. Baird restated a “neutral” rating and issued a $118.00 price objective (down from $137.00) on shares of Itron in a research report on Friday, October 31st. Oppenheimer set a $145.00 price objective on Itron and gave the stock an “outperform” rating in a research report on Friday, October 31st. Stephens raised shares of Itron from an “equal weight” rating to an “overweight” rating and set a $130.00 target price for the company in a research note on Monday, November 3rd. Finally, Baird R W lowered shares of Itron from a “strong-buy” rating to a “hold” rating in a report on Friday, October 31st. Nine analysts have rated the stock with a Buy rating and five have issued a Hold rating to the stock. According to data from MarketBeat, Itron has a consensus rating of “Moderate Buy” and an average price target of $139.00.

Itron Trading Down 0.9%

Shares of ITRI stock opened at $94.23 on Monday. The stock has a market cap of $4.32 billion, a P/E ratio of 16.95, a P/E/G ratio of 0.46 and a beta of 1.52. Itron has a fifty-two week low of $90.11 and a fifty-two week high of $142.00. The business has a fifty day simple moving average of $102.95 and a 200-day simple moving average of $118.94. The company has a quick ratio of 1.91, a current ratio of 2.17 and a debt-to-equity ratio of 0.46.

Itron (NASDAQ:ITRI) last announced its earnings results on Thursday, October 30th. The scientific and technical instruments company reported $1.54 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.48 by $0.06. Itron had a net margin of 10.69% and a return on equity of 17.82%. The company had revenue of $581.63 million during the quarter, compared to analysts’ expectations of $578.49 million. During the same quarter in the previous year, the business posted $1.84 earnings per share. The firm’s quarterly revenue was down 5.5% compared to the same quarter last year. Itron has set its FY 2025 guidance at 6.840-6.940 EPS and its Q4 2025 guidance at 2.150-2.250 EPS. On average, analysts forecast that Itron will post 5.33 earnings per share for the current fiscal year.

Insider Activity

In other news, SVP Christopher E. Ware sold 343 shares of the company’s stock in a transaction on Monday, November 24th. The stock was sold at an average price of $96.51, for a total transaction of $33,102.93. Following the completion of the sale, the senior vice president directly owned 18,774 shares in the company, valued at $1,811,878.74. This represents a 1.79% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available at this link. Also, CFO Joan S. Hooper sold 948 shares of Itron stock in a transaction on Monday, November 24th. The shares were sold at an average price of $96.51, for a total value of $91,491.48. Following the completion of the transaction, the chief financial officer owned 87,446 shares in the company, valued at $8,439,413.46. The trade was a 1.07% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold a total of 2,971 shares of company stock valued at $286,731 in the last ninety days. 1.51% of the stock is owned by company insiders.

Hedge Funds Weigh In On Itron

A number of large investors have recently modified their holdings of the company. Impax Asset Management Group plc lifted its holdings in Itron by 127.3% in the 3rd quarter. Impax Asset Management Group plc now owns 1,588,950 shares of the scientific and technical instruments company’s stock worth $197,153,000 after buying an additional 890,040 shares in the last quarter. Norges Bank acquired a new position in shares of Itron in the second quarter worth about $71,727,000. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC boosted its holdings in Itron by 129.7% in the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 732,274 shares of the scientific and technical instruments company’s stock valued at $76,713,000 after purchasing an additional 413,487 shares during the last quarter. Merewether Investment Management LP boosted its holdings in Itron by 1,552.7% in the second quarter. Merewether Investment Management LP now owns 300,787 shares of the scientific and technical instruments company’s stock valued at $39,593,000 after purchasing an additional 282,587 shares during the last quarter. Finally, Arrowstreet Capital Limited Partnership grew its stake in Itron by 42.5% during the 3rd quarter. Arrowstreet Capital Limited Partnership now owns 604,580 shares of the scientific and technical instruments company’s stock valued at $75,306,000 after purchasing an additional 180,366 shares in the last quarter. 96.19% of the stock is currently owned by hedge funds and other institutional investors.

Itron Company Profile

Itron, Inc (NASDAQ: ITRI) is a global technology company that develops innovative solutions to measure, manage and analyze the use of energy and water. Its comprehensive portfolio includes smart meters, data collection devices, communication networks and advanced software applications designed to optimize utility operations and foster sustainable resource management. The company’s offerings enable utilities and cities to accurately monitor consumption patterns, streamline billing processes and improve grid reliability.

Itron’s product lineup spans a range of hardware and software solutions, from residential and commercial smart meters to meter data management systems (MDMS), networked communication platforms and analytics tools.